University of Vermont Spatial Analysis Lab

Ward Lab, located in Burlington, VT, conducts research on Toxoplasma gondii, a highly prevalent parasite that infects varying warm-blooded animals, including humans. The lab aims to uncover the sophisticated mechanisms used by the parasite for host cell invasion and motility, with the intent of developing innovative treatments for associated diseases. Led by Professor Gary Ward, the lab's team comprises postdoctoral researchers, graduate students, and technicians dedicated to exploring the complex interactions between T. gondii and its hosts. Through rigorous research and a portfolio of significant publications, they strive to advance understanding in the field of parasitology. Generated from the website

The University of Vermont (UVM) in Burlington, VT, is dedicated to providing a peak academic experience that fosters student success through a wide array of academic programs, including bachelor's, master's, and doctoral degrees, alongside various certificates and minors. With a commitment to research as a public good, UVM emphasizes inclusivity and engagement within its diverse community of students, faculty, and alumni. Achieving Carnegie R1 Research status, UVM stands among the top research institutions in the United States, reflecting its dedication to advancing knowledge and innovation. The university supports its students with generous financial aid and scholarship opportunities, ensuring that 92% of undergraduates have access to financial assistance, and helping 94% of graduates secure employment or continue their education shortly after graduation. Generated from the website

Green Mountain Antibodies is a biotechnology company in Burlington, Vt., specializing in custom monoclonal antibody manufacturing. Its customers include pharmaceutical companies, biotech companies and research investigators. The company s services include developing custom hibridomas, culturing cells and immunochemistry. Green Mountain Antibodies in-house monoclonal product line has experience in coagulation and fibrinolysis proteins. Projects requiring an antibody, the company s staff can generate hybridoma, produce and purify the antibody and assist in developing the necessary assay. Green Mountain Antibodies was founded in 1994.